Product image of Mestinon (Pyridostigmine Bromide) supplied by GNH India

Mestinon

Active Ingredient:
Pyridostigmine Bromide
Origin:
EU

Mestinon (Pyridostigmine Bromide)

Pyridostigmine bromide, the active ingredient in Mestinon, is a cholinesterase inhibitor presented as an oral dosage form for oral use. It is used to improve neuromuscular transmission in patients with myasthenia gravis.

GNH India supplies Mestinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Healthcare Nv/Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Mestinon is a cholinesterase inhibitor indicated for disorders of neuromuscular transmission.
  • Myasthenia gravis: enhances muscle strength by increasing acetylcholine availability at the neuromuscular junction.

How It Works

  • Pyridostigmine bromide reversibly inhibits acetylcholinesterase, the enzyme that degrades acetylcholine. By blocking this enzyme, the drug raises acetylcholine concentrations at the neuromuscular junction, thereby improving transmission of nerve impulses to skeletal muscles and reducing the characteristic weakness of myasthenia gravis.

Side Effects

Mestinon may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects

  • Nausea and vomiting
  • Diarrhea or abdominal cramps
  • Increased salivation or sweating
  • Muscle cramps or fasciculations
  • Dizziness or headache
  • Blurred vision

Serious or Rare Side Effects

  • Cholinergic crisis (muscle weakness, respiratory failure)
  • Severe bronchospasm or airway obstruction
  • Cardiac arrhythmias (bradycardia, atrioventricular block)
  • Severe hypotension
  • Allergic reactions (rash, angioedema, anaphylaxis)

Precautions & Warnings

  • Before prescribing Mestinon, clinicians should consider several safety aspects.
  • Renal impairment: adjust dose based on renal function.
  • Asthma or COPD: monitor for bronchospasm.
  • Concurrent anticholinergic therapy: avoid abrupt discontinuation.
  • Pregnancy and lactation: safety not established; weigh benefits against risks.
  • Elderly patients: start with lower doses and titrate slowly.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Mestinon can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Anticholinergic agents (e.g., atropine, scopolamine): may negate therapeutic effect.
  • Succinylcholine: potentiates neuromuscular blockade.
  • Other cholinesterase inhibitors: risk of cholinergic excess.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may exacerbate bradycardia.
  • Magnesium supplements: can enhance neuromuscular transmission effects.
  • Certain antibiotics (e.g., fluoroquinolones): may increase risk of tendon disorders.
  • Diuretics: monitor electrolyte balance.

Frequently Asked Questions

Mestinon contains pyridostigmine bromide and is prescribed to improve muscle strength in patients with myasthenia gravis, a condition caused by impaired neuromuscular transmission.

The drug reversibly inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine, thereby increasing acetylcholine levels at the neuromuscular junction and enhancing muscle contraction.

The dosage of Mestinon is individualized; the prescribing clinician determines the appropriate amount based on the patient’s condition, response, and renal function.

Safety data for pyridostigmine bromide in pregnancy and lactation are limited. Clinicians should assess the potential benefits against possible risks before prescribing to pregnant or nursing women.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mestinon (pyridostigmine) is a reversible, short‑acting cholinesterase inhibitor commonly used for myasthenia gravis. Compared with longer‑acting agents like neostigmine, pyridostigmine has a more favorable side‑effect profile and is preferred for chronic outpatient management.

Store Mestinon at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly sealed.

Mestinon is taken orally, usually as tablets. It should be swallowed with water and can be taken with or without food, following the dosing schedule prescribed by the healthcare professional.

The most serious risks include cholinergic crisis, which can cause severe muscle weakness and respiratory failure, as well as cardiac arrhythmias and bronchospasm. Prompt medical attention is required if these symptoms develop.

Patients with known hypersensitivity to pyridostigmine or any component of the formulation, those with uncontrolled asthma or severe COPD, and individuals taking potent anticholinergic drugs should avoid using Mestinon unless closely supervised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pyridostigmine Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT